• LAST PRICE
    1.4800
  • TODAY'S CHANGE (%)
    Trending Down-0.0700 (-4.5161%)
  • Bid / Lots
    1.4600/ 2
  • Ask / Lots
    1.5400/ 1
  • Open / Previous Close
    1.5400 / 1.5500
  • Day Range
    Low 1.4700
    High 1.5400
  • 52 Week Range
    Low 1.1200
    High 3.6200
  • Volume
    61,717
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.55
TimeVolumeMIST
02:36 ET3401.49
02:47 ET1001.485
03:20 ET1001.49
03:30 ET4031.486
03:32 ET1001.48
03:41 ET2001.48
03:54 ET42001.485
03:56 ET15921.5
03:59 ET9721.48
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMIST
Milestone Pharmaceuticals Inc
82.6M
-1.2x
---
United StatesCMRX
Chimerix Inc
84.5M
-1.0x
---
United StatesPMVP
PMV Pharmaceuticals Inc
82.8M
-1.2x
---
United StatesGNLX
Genelux Corp
84.2M
-2.3x
---
United StatesTLSA
Tiziana Life Sciences Ltd
83.5M
-5.7x
---
United StatesLPTX
Leap Therapeutics Inc
84.2M
-0.9x
---
As of 2024-07-19

Company Information

Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.

Contact Information

Headquarters
420-1111 boul. Dr.-Frederik-PhilipsMONTREAL, QC, Canada H4M 2X6
Phone
514-336-0444
Fax
514-336-0444

Executives

Non-Executive Independent Chairman of the Board
Robert Wills
President, Chief Executive Officer
Joseph Oliveto
Chief Financial Officer, Executive Vice President of Corporate Development
Amit Hasija
Chief Operating Officer
Jeffrey Nelson
Chief Medical Officer
David Bharucha

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$82.6M
Revenue (TTM)
$0.00
Shares Outstanding
53.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.65
EPS
$-1.25
Book Value
$0.50
P/E Ratio
-1.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.